The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

SureCN222517     (8S,9S,13S,14S)-2,3- dihydroxy-13-methyl-7...

Synonyms: CCRIS 9276, CHEBI:1156, AG-J-96015, CHEMBL1627343, HMDB00343, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Catecholestrone


Psychiatry related information on Catecholestrone


High impact information on Catecholestrone


Chemical compound and disease context of Catecholestrone


Biological context of Catecholestrone


Anatomical context of Catecholestrone


Associations of Catecholestrone with other chemical compounds


Gene context of Catecholestrone


Analytical, diagnostic and therapeutic context of Catecholestrone


  1. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. Ursin, G., London, S., Stanczyk, F.Z., Gentzschein, E., Paganini-Hill, A., Ross, R.K., Pike, M.C. J. Natl. Cancer Inst. (1999) [Pubmed]
  2. Absence of a suppressive effect of 2-hydroxyestrone on hyperprolactinemia in patients with prolactinomas before and after estradiol administration. Lamberts, S.W., Oosterom, R. J. Clin. Endocrinol. Metab. (1983) [Pubmed]
  3. Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Atkinson, C., Lampe, J.W., Tworoger, S.S., Ulrich, C.M., Bowen, D., Irwin, M.L., Schwartz, R.S., Rajan, B.K., Yasui, Y., Potter, J.D., McTiernan, A. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  4. Suppression of prolactin secretion in normal young women by 2-hydroxyestrone. Fishman, J., Tulchinsky, D. Science (1980) [Pubmed]
  5. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. Schneider, J., Huh, M.M., Bradlow, H.L., Fishman, J. J. Biol. Chem. (1984) [Pubmed]
  6. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Brooks, J.D., Ward, W.E., Lewis, J.E., Hilditch, J., Nickell, L., Wong, E., Thompson, L.U. Am. J. Clin. Nutr. (2004) [Pubmed]
  7. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Fowke, J.H., Longcope, C., Hebert, J.R. Cancer Epidemiol. Biomarkers Prev. (2000) [Pubmed]
  8. Physical activity, body size, and estrogen metabolism in women. Matthews, C.E., Fowke, J.H., Dai, Q., Leon Bradlow, H., Jin, F., Shu, X.O., Gao, Y.T., Longcope, C., Hebert, J.R., Zheng, W. Cancer Causes Control (2004) [Pubmed]
  9. The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Russell, J.B., Mitchell, D., Musey, P.I., Collins, D.C. Obstetrics and gynecology. (1984) [Pubmed]
  10. Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Bradlow, H.L., Sepkovic, D.W., Telang, N.T., Osborne, M.P. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  11. Role of the estrogen receptor in the action of organochlorine pesticides on estrogen metabolism in human breast cancer cell lines. Bradlow, H.L., Davis, D., Sepkovic, D.W., Tiwari, R., Osborne, M.P. Sci. Total Environ. (1997) [Pubmed]
  12. The excretion of 2-hydroxyestrone during the menstrual cycle. Ball, P., Gelbke, H.P., Knuppen, R. J. Clin. Endocrinol. Metab. (1975) [Pubmed]
  13. Excretion of 2-hydroxyestrone in urine throughout human pregnancies. Gelbke, H.P., Böttger, M., Knuppen, R. J. Clin. Endocrinol. Metab. (1975) [Pubmed]
  14. Metabolism of catechol estrogen by human erythrocytes. Bates, G.W., Edman, C.D., Porter, J.C., MacDonald, P.C. J. Clin. Endocrinol. Metab. (1977) [Pubmed]
  15. Suppression of the preovulatory luteinizing hormone surge in the rat by 2-hydroxyestrone: relationship to endogenous estradiol levels. Okatani, Y., Fishman, J. Endocrinology (1984) [Pubmed]
  16. Formation of 2- and 4-hydroxyestrogens by brain, pituitary, and liver of the human fetus. Ball, P., Knuppen, R. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  17. Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited. Mesia-Vela, S., Sanchez, R.I., Li, J.J., Li, S.A., Conney, A.H., Kauffman, F.C. Carcinogenesis (2002) [Pubmed]
  18. Inhibition of the preovulatory LH surge after a catecholestrogen (2-hydroxyestrone) antiserum injection in the third ventricle of cycling female rats. Villard, M.F., Ladosky, W., Janots, D., Lenoir, V., Adeline, J., Kerdelhué, B., Scholler, R. Neurosci. Lett. (1987) [Pubmed]
  19. Metabolism of [4-14C]estrone in hamster and rat hepatic and renal microsomes: species-, sex- and age-specific differences. Haaf, H., Metzler, M., Li, J.J. J. Steroid Biochem. Mol. Biol. (1992) [Pubmed]
  20. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. Lotinun, S., Westerlind, K.C., Turner, R.T., Turner, R.T. J. Endocrinol. (2001) [Pubmed]
  21. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Lee, A.J., Cai, M.X., Thomas, P.E., Conney, A.H., Zhu, B.T. Endocrinology (2003) [Pubmed]
  22. 2-Hydroxyestrone suppresses and 2-methoxyestrone augments the preovulatory prolactin surge in the cycling rat. Katayama, S., Fishman, J. Endocrinology (1982) [Pubmed]
  23. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Bolton, J.L., Shen, L. Carcinogenesis (1996) [Pubmed]
  24. Inhibition of dihydropteridine reductase by catechol estrogens. Shen, R.S., Abell, C.W. J. Neurosci. Res. (1983) [Pubmed]
  25. cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3. Mojarrabi, B., Butler, R., Mackenzie, P.I. Biochem. Biophys. Res. Commun. (1996) [Pubmed]
  26. A phase I study of indole-3-carbinol in women: tolerability and effects. Reed, G.A., Peterson, K.S., Smith, H.J., Gray, J.C., Sullivan, D.K., Mayo, M.S., Crowell, J.A., Hurwitz, A. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  27. Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens. Vallée, M., Albert, C., Beaudry, G., Hum, D.W., Bélanger, A. J. Steroid Biochem. Mol. Biol. (2001) [Pubmed]
  28. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Li, S.A., Purdy, R.H., Li, J.J. Carcinogenesis (1989) [Pubmed]
  29. Rapid metabolic clearance of the catechol estrogen 2-hydroxyestrone. Merriam, G.R., Brandon, D.D., Kono, S., Davis, S.E., Loriaux, D.L., Lipsett, M.B. J. Clin. Endocrinol. Metab. (1980) [Pubmed]
  30. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Falk, R.T., Rossi, S.C., Fears, T.R., Sepkovic, D.W., Migella, A., Adlercreutz, H., Donaldson, J., Bradlow, H.L., Ziegler, R.G. Cancer Epidemiol. Biomarkers Prev. (2000) [Pubmed]
  31. Urinary estrogen metabolites and breast cancer: a case-control study. Kabat, G.C., Chang, C.J., Sparano, J.A., Sepkovie, D.W., Hu, X.P., Khalil, A., Rosenblatt, R., Bradlow, H.L. Cancer Epidemiol. Biomarkers Prev. (1997) [Pubmed]
  32. Effect of intraventricular administration of catechol estrogens on catecholamine content in various brain regions. Panek, D.U., Dixon, W.R. Brain Res. (1985) [Pubmed]
  33. The Physical Activity for Total Health (PATH) Study: rationale and design. McTiernan, A., Ulrich, C.M., Yancey, D., Slate, S., Nakamura, H., Oestreicher, N., Bowen, D., Yasui, Y., Potter, J., Schwartz, R. Medicine and science in sports and exercise. (1999) [Pubmed]
WikiGenes - Universities